Q
Quoin Pharmaceuticals, Ltd. (QNRX)
NCM – Real vaqt narxi. Valyuta: USD
4.45
+0.25 (5.95%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
4.34
-0.11 (-2.42%)
Bozordan keyin: Jun 26, 2026, 7:58 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
4.45
+0.25 (5.95%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
4.34
-0.11 (-2.42%)
Bozordan keyin: Jun 26, 2026, 7:58 PM EDT
Daromad taqsimoti ma'lumotlari hali hisoblanmagan.
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 2.87 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 2.87 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.00 | 0.30 | 10 | |
| Qarz/Aktivlar nisbati | 0.00 | 1.04 | 10 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 8.2 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | N/A | N/A | N/A | N/A | N/A |
| Yalpi foyda | -104K | -103K | -100K | -101K | -101K |
| Operatsion daromad | -8M | -9M | -10M | -16M | -18M |
| Sof foyda | -9M | -9M | -9M | -16M | -17M |
| EBITDA | -8M | -9M | -9M | -16M | -17M |
| NOMI | KOEFF. | SANOAT | 5 YIL | BALL |
|---|---|---|---|---|
| Yalpi marja % | N/A | -11.73 | 1.0 | |
| Operatsion marja % | N/A | -24.60 | 1.0 | |
| Sof marja % | N/A | -172.20 | 1.0 | |
| EBITDA marja % | N/A | -201.27 | 1.0 | |
| Pul oqimi marja % | N/A | -156.39 | 1.0 | |
| O‘rtacha ball | 1.0 | |||
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | 74.36 | 5.5 |
| Keyingi chorak | N/A | 76.42 | 5.5 |
| Joriy yil | N/A | 57.06 | 5.5 |
| Keyingi yil | N/A | 54.84 | 5.5 |
| O‘rtacha ball | 5.5 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 999 | -13.9 | -1.71 | 4.44 | 4.0 |
| Yil/Yil | 999 | -31.42 | 72.77 | -88.15 | 5.5 |
| 3 yil o‘rtacha | 999 | -24.5 | 79.15 | -21.01 | 5.5 |
| 5 yil o‘rtacha | 999 | -186.97 | 82.92 | -88.12 | 5.5 |
| O‘rtacha ball | 5.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Naqd pul zahiralari $3.1M kelgusi qarz to'lovlarini $0.0 zo'rg'a qoplaydi
Jami joriy aktivlar $15.3M jami joriy majburiyatlardan $5.3M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.0) tarmoq o'rtachasiga yaqin bo'lib, muvozanatli leverajni aks ettiradi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$4.9M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi